GenScript Biotech Corp (GenScript) is a biotechnology company. It offers comprehensive life science research services and products comprising custom gene synthesis and molecular biology, custom protein expression and purification, custom peptide synthesis, custom cell line development, catalog antibodies, and catalog kits. GenScript operates its business through four segments – Life-Science Services and Products, Biologics Contract Development Services, Industrial Synthetic Biology Products, and Cell Therapy. The Life-Science Services and Products segment offers services and products for gene synthesis, oligonucleotide synthesis, peptide synthesis, protein production, antibody development, and life-science equipment and consumables. GenScript provides preclinical drug development services such as in vitro pharmacology, in vivo pharmacology, and antibody/protein engineering services. The company’s contract development and manufacturing organization (CDMO) platform offers gene and cell therapy (GCT) development, and biologics discovery and development services. The industrial synthetic products platform develops products for food and feed processing and other industrial uses. The cell therapy platform provides cell therapy solutions to patients with refractory diseases including cancer and inflammatory diseases.
You have successfully subscribed and will receive the next available issues